Characterisation of ACTH Peptides in Human Skin and Their Activation of the Melanocortin-1 Receptor

Authors

  • KAZUMASA WAKAMATSU,

    1. Department of Dermatology, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Search for more papers by this author
    • *

      Visiting Research Fellow. Present Address: Fujita Health University, School of Health Sciences, Toyoake, Aichi, 470-11, Japan.

  • ALISON GRAHAM,

    1. Department of Dermatology, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Search for more papers by this author
  • DAVID COOK,

    1. Department of Clinical Biochemistry, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Search for more papers by this author
  • ANTHONY J. THODY

    Corresponding author
    1. Department of Dermatology, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Search for more papers by this author

  • Presented in part at the European Society for Dermatological Research Meeting, Amsterdam, September 1996 and at the XVI International Pigment Cell Conference, Anaheim, October 1996.

Address reprint requests to Professor A. J. Thody, Department of Dermatology, University of Newcastle upon Tyne, Medical School, Newcastle Tyne, NE2 4HH, United Kingdom.

Abstract

α-Melanocyte-stimulating hormone (α-MSH) is a proopiomelanocortin (POMC)-derived peptide, which is produced in the pituitary and at other sites including the skin. It has numerous effects and in the skin has a pigmentary action through the activation of the melanocortin-1 (MC-1) receptor, which is expressed by melanocytes. Recent evidence suggests that the related POMC peptides such as adrenocorticotrophin (ACTH), which is the precursor of α-MSH, is also an agonist at the MC-1 receptor. By using immunocytochemistry, we confirmed the presence of α-MSH in human skin where staining was evident in keratinocytes and especially strong in melanocytes and possibly Langerhans cells. ACTH was also present and tended to show the strongest reaction in differentiated keratinocytes. Immunostaining was also observed for the prohormone convertases, PC1 and PC2, which are involved in the formation of ACTH and its cleavage to α-MSH, respectively. The amounts of immunoreactive ACTH exceeded those of α-MSH. Using HPLC we identified for the first time the presence of ACTH1-39, ACTH1-17, ACTH1-10, acetylated ACTH1-10, α-MSH, and desacetyl α-MSH in epidermis and in cultured keratinocytes. The ability of these peptides to activate the human MC-1 receptor was examined in HEK 293 cells that had been transfected with the receptor. All peptides increased adenylate cyclase in these cells with the following order of potency: ACTH1-17 > α-MSH > ACTH1-39 > desacetyl α-MSH > acetylated ACTH1-10 > ACTH1-10. ACTH1-17 also increased the dendricity and melanin content of cultured human melanocytes indicating that the peptide was able to activate MC-1 receptors when present in their normal location. However, as found with α-MSH, not all cultures were responsive and, as we have previously suggested, we suspect that this was the result of changes at the MC-1 receptor. Nevertheless, it would appear that ACTH peptides can serve as natural ligands of the MC-1 receptor on human melanocytes and their presence in the skin suggests that, together with α-MSH, they may have a role in the regulation of human melanocytes.

Ancillary